First Time Loading...

Fusion Antibodies PLC
LSE:FAB

Watchlist Manager
Fusion Antibodies PLC Logo
Fusion Antibodies PLC
LSE:FAB
Watchlist
Price: 3.85 GBX -2.53%
Updated: Mar 28, 2024

ROA
Return on Assets

-93.9%
Current
-47%
Average
-4.3%
Industry
Negative for the last year
-93.9%
Negative average
-47%
Worse than average
Worse than industry value

ROA, or Return on Assets, is an indicator of how well a company utilizes its assets in terms of profitability. This number tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. A higher ROA indicates more efficient use of assets to produce earnings, making it a valuable gauge for investors assessing a company's operational efficiency and profitability potential.

ROA
-93.9%
=
Net Income
-2.8m
/
Total Assets
3m

ROA Across Competitors

ROA Comparison
Fusion Antibodies PLC Competitors

Country UK
Market Cap 3.7m GBP
ROA
-94%
Country US
Market Cap 224B USD
ROA
6%
Country US
Market Cap 183.9B USD
ROA
6%
Country US
Market Cap 45.8B USD
ROA
5%
Country KR
Market Cap 59.3T KRW
ROA
5%
Country US
Market Cap 43.2B USD
ROA
11%
Country CH
Market Cap 39.4B CHF
ROA
4%
Country US
Market Cap 29B USD
ROA
16%
Country US
Market Cap 28.8B USD
ROA
23%
Country IE
Market Cap 27.2B USD
ROA
4%
Country FR
Market Cap 24.1B EUR
ROA
5%

ROA Distribution

ROA Distribution
Life Sciences Tools & Services Industry

Profitability Report

View the profitability report to see the full profitability analysis for Fusion Antibodies PLC.

See Also

Discover More
What is Return on Assets?

ROA, or Return on Assets, is an indicator of how well a company utilizes its assets in terms of profitability. This number tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. A higher ROA indicates more efficient use of assets to produce earnings, making it a valuable gauge for investors assessing a company's operational efficiency and profitability potential.

ROA
-93.9%
=
Net Income
-2.8m
/
Total Assets
3m
What is the ROA of Fusion Antibodies PLC?

Based on Fusion Antibodies PLC's most recent financial statements, the company has ROA of -93.9%.